ELIZABETH CHANDLER: Open Payments
NPI 1144477472 · BALTIMORE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$10,997 in 63 payments from 12 companies in 2025. Trend: 2023 $489 · 2024 $4,559 · 2025 $10,997
Speaker / faculty: $8,613Food & beverage: $1,810Travel & lodging: $575
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 31 | $6,257 |
| PFIZER INC. | 7 | $3,404 |
| Ipsen Innovation | 5 | $745 |
| Lundbeck LLC | 5 | $219 |
| Biogen, Inc. | 6 | $140 |
| Eisai Inc. | 2 | $64 |
| GENZYME CORPORATION | 2 | $44 |
| Genentech USA, Inc. | 1 | $32 |
| Axsome Therapeutics, Inc. | 1 | $29 |
| Lilly USA, LLC | 1 | $23 |
Products named: QULIPTA, NURTEC ODT, UBRELVY, VYEPTI, VUMERITY, Leqembi, Ocrevus Zunovo, Symbravo.
Industry payments across MD — which companies pay providers there.
